• 1. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 2. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 3. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 4. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 5. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293

• Solvents and Organic Chemicals Organic Compounds Benzenoids Naphthalenes Naphthalenes
• Solvents and Organic Chemicals Organic Compounds Benzenoids Naphthalenes
• Other Chemical Reagents Derivatization Reagents
• Solvents and Organic Chemicals Organic Compounds Acids/Esters

Introduction to 4-Bromonaphthalene-1-boronic acid (CAS No. 145965-14-6)

4-Bromonaphthalene-1-boronic acid is a specialized organoboron compound that has garnered significant attention in the field of synthetic chemistry and pharmaceutical research due to its versatile applications. As a derivative of naphthalene, this compound features a bromine substituent at the 4-position and a boronic acid functional group at the 1-position, making it a valuable intermediate in cross-coupling reactions, particularly Suzuki-Miyaura couplings. The chemical structure of 4-Bromonaphthalene-1-boronic acid (CAS No. 145965-14-6) imparts unique reactivity that facilitates the construction of complex molecular frameworks, which are essential in drug discovery and material science.

The significance of 4-Bromonaphthalene-1-boronic acid lies in its role as a building block for the synthesis of biaryl compounds. Biaryl structures are prevalent in many pharmacologically active molecules, including anticancer agents and central nervous system (CNS) drugs. The boronic acid moiety enables efficient palladium-catalyzed coupling with aryl halides or triflates, allowing for the introduction of diverse aryl groups into the naphthalene core. This reaction is particularly useful in generating derivatives with tailored biological activities.

Recent advancements in pharmaceutical chemistry have highlighted the utility of 4-Bromonaphthalene-1-boronic acid in the development of targeted therapies. For instance, researchers have leveraged this compound to synthesize novel inhibitors of kinases and other enzymes implicated in diseases such as cancer and inflammatory disorders. The ability to precisely modify the naphthalene scaffold through cross-coupling reactions has led to the discovery of compounds with improved potency and selectivity.

In addition to its pharmaceutical applications, 4-Bromonaphthalene-1-boronic acid has found utility in materials science, particularly in the synthesis of organic electronic materials. The conjugated system of the naphthalene ring enhances electron delocalization, making it an attractive component for organic light-emitting diodes (OLEDs) and photovoltaic devices. By incorporating functional groups via cross-coupling strategies, chemists can fine-tune the electronic properties of these materials for optimal performance.

The synthesis of 4-Bromonaphthalene-1-boronic acid typically involves halogenation followed by lithiation and subsequent boronation. This multi-step process highlights the compound's synthetic versatility but also underscores the need for high-purity reagents to ensure optimal yields and minimal side reactions. Advances in catalytic systems have improved the efficiency of these transformations, making large-scale production more feasible.

Current research is exploring novel methodologies for enhancing the reactivity of 4-Bromonaphthalene-1-boronic acid. For example, studies have investigated the use of photoredox catalysis to facilitate selective functionalization at different positions on the naphthalene ring. Such approaches could expand the compound's utility in constructing structurally diverse libraries for high-throughput screening.

The role of 4-Bromonaphthalene-1-boronic acid in medicinal chemistry is further underscored by its incorporation into drug candidates targeting rare diseases. By enabling rapid diversification of molecular structures, this compound has accelerated the discovery pipeline for therapies that address unmet medical needs. Collaborative efforts between academic institutions and pharmaceutical companies continue to drive innovation in this area.

Looking ahead, the demand for 4-Bromonaphthalene-1-boronic acid is expected to grow as new synthetic techniques emerge and therapeutic applications expand. The compound's ability to serve as a versatile intermediate ensures its continued relevance in both academic research and industrial settings. As methodologies for green chemistry and sustainable synthesis evolve, optimizing processes for producing 4-Bromonaphthalene-1-boronic acid will remain a key focus.

In conclusion, 4-Bromonaphthalene-1-boronic acid (CAS No. 145965-14-6) represents a cornerstone in modern synthetic chemistry, bridging gaps between fundamental research and practical applications. Its contributions to drug development, materials science, and catalysis underscore its importance as a chemical building block for tomorrow's innovations.

• 641144-16-3(10-Bromoanthracene-9-boronic acid)
• 5467-74-3((4-bromophenyl)boronic acid)
• 117695-55-3((3,5-dibromophenyl)boronic acid)
• 89598-96-9(3-Bromophenylboronic acid)
• 1442457-44-4((3-BROMONAPHTHALEN-1-YL)BORONIC acid)
• 131838-19-2(Boronic acid,B-(5-bromo-1-naphthalenyl)-)
• 167105-03-5(8-bromonaphthalen-1-yl)boronic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)